Endometrial Cancer, Endometrial Intraepithelial Neoplasia, Fertility-sparing Surgery
Conditions
Brief summary
We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia
Detailed description
A multi-center prospective study on the oncological and reproductive outcomes and quality of life in young woman after fertility-sparing treatment of endometrial cancer and endometrial intraepithelial hyperplasia
Interventions
None listed
Sponsors
Region Stockholm
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
* Fertility sparing treatment of EC and EIN. * 18-45 Years old * From start study (Jan 2025 - end study Jan 2028) * All centras in Sweden
Exclusion criteria
* Not English och Swedish speaking
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Relaps of endometrial cancer or EIN after fertility-sparing treatment | from enrollment to 2 years after fertility-sparing treatment | Relaps of endometrial cancer or EIN after fertility-sparing treatment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN | From start of study to 2 years after fertility-sparing treatment | Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN |
Contacts
Primary ContactCharlotta CR Riese, MD, PHD-student
Backup ContactKenny Rodriguez Wallberg, Proffessor
Outcome results
None listed